alternatives to glp-1 weight loss medications FDA approves Foundayo, an oral alternative Wegovy and Ozempic List of approved and pending
Description
Industry reports project ~13% annual growth in the GLP-1 peptide CDMO market through 2034 ( [13] )

doi: 10.1016/j.bbr.2018.08.006 [DOI] [PubMed] [Google Scholar] 128.Al Qassab M, Mneimneh M, Jradi A, et al

Another medication in the works is dapiglutide, a blend of GLP-1 and GLP-2 agonists, and there are more therapies coming down the pike
However, GLP-1s are generally well tolerated , with most side effects being manageable and going with time

Current Recommendations GLP-1 medications are not recommended during breastfeeding
